Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (351-360 of 567) with videos related to

Pageof 57
Sort By:
Journal of the American College of Cardiology|December 19, 1998
Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trialK P Alexander, E D Peterson, C B Granger, et al.
Circulation|March 15, 1995
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I InvestigatorsK L Lee, L H Woodlief, E J Topol, et al.
Journal of the American College of Cardiology|January 13, 1998
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary ArteriesA Betriu, R M Califf, X Bosch, et al.
JAMA|January 22, 1992
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery diseaseR B Williams, J C Barefoot, R M Califf, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
International Journal of Cardiology|May 1, 1989
Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study GroupE M Antman, W D Dupont, J Bonalsky, et al.
The American Journal of Cardiology|September 15, 1996
Depression and long-term mortality risk in patients with coronary artery diseaseJ C Barefoot, M J Helms, D B Mark, et al.
JAMA|July 4, 2001
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary interventionK M Akkerhuis, J W Deckers, A M Lincoff, et al.
Statistics in Medicine|August 21, 2001
Using observational data to estimate prognosis: an example using a coronary artery disease registryE R DeLong, C L Nelson, J B Wong, et al.
The New England Journal of Medicine|August 14, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study GroupM Cohen, C Demers, E P Gurfinkel, et al.
Pageof 57

Showing results (351-360 of 567) with videos related to

Sort By:
Pageof 57
Journal of the American College of Cardiology|December 19, 1998
Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trialK P Alexander, E D Peterson, C B Granger, et al.
Circulation|March 15, 1995
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I InvestigatorsK L Lee, L H Woodlief, E J Topol, et al.
Journal of the American College of Cardiology|January 13, 1998
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary ArteriesA Betriu, R M Califf, X Bosch, et al.
JAMA|January 22, 1992
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery diseaseR B Williams, J C Barefoot, R M Califf, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
International Journal of Cardiology|May 1, 1989
Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study GroupE M Antman, W D Dupont, J Bonalsky, et al.
The American Journal of Cardiology|September 15, 1996
Depression and long-term mortality risk in patients with coronary artery diseaseJ C Barefoot, M J Helms, D B Mark, et al.
JAMA|July 4, 2001
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary interventionK M Akkerhuis, J W Deckers, A M Lincoff, et al.
Statistics in Medicine|August 21, 2001
Using observational data to estimate prognosis: an example using a coronary artery disease registryE R DeLong, C L Nelson, J B Wong, et al.
The New England Journal of Medicine|August 14, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study GroupM Cohen, C Demers, E P Gurfinkel, et al.
Pageof 57